Dr. Irina A. Anselm M.D.

Recommended Articles

• Lemtrada Gains FDA Approval to Treat Multiple Sclerosis

  In the United States alone, over 400,000 individuals are dealing with the challenges associated with multiple sclerosis (MS). Most recently, Sanofi, an international leader in healthcare, announced FDA approval of the prescription drug Lemtrada, for the treatment of patients with relapsing forms of...

• The Osbourne Family Partners with Teva for Multiple Sclerosis Campaign

  One of the people affected by lack of information about MS is Jack Osbourne, son of Ozzy and Sharon Osbourne. He was diagnosed with the relapsing remitting form of multiple sclerosis back in 2012. Spurred on by the uncertainty caused by his diagnosis, he partnered with Teva to establish a campaign...

• Multiple Sclerosis: Coping with Grief

  Just hearing the word grief can evoke feelings of sadness, but is grief just “being sad”? Or is it something more complex? The word itself seems to have a stronger meaning than “sad.”According to the Mayo Clinic, for many people, including those diagnosed with a chronic illness, grief is a...

• Montell Williams's Journey with Multiple Sclerosis and Medical Marijuana

  Sometimes it seems like multiple sclerosis has a mind all of its own. Patients can never be entirely sure when symptoms are going to flare up and cause severe problems, and they can never be quite sure when those symptoms will subside. On top of that, multiple sclerosis can be difficult to diagnose...

• Dr. Bill Petit, Only Survivor of Brutal Slaying of Family, Honors Wife with MS Foundation

  Bill Petit, the lone survivor in the brutal home invasion that left his entire family dead, has come into the spotlight lately as he considers running for office. He explains that the heartbreak never really does go away, but it does get easier. He says, "I used to have gut wrenching weeks in a...

• Fighting Alzheimer’s by Flying Around the World

  Dr. Ed Galkin, 82, wants to find a cure for Alzheimer’s disease. His older brother died from compilations of Alzheimer’s two years ago, and Dr. Galkin does not want to see this happen for others. ...